Madrid Newborn Sickle Cell Disease Cohort: clinical outcomes, stroke prevention and survival Marina García-MorinEduardo J. Bardón-CanchoElena Cela Original Article 18 November 2023 Pages: 373 - 383
Molecular characteristics of hereditary red blood cell membrane disorders in Thailand: a multi-center registry Duantida SongdejPacharapan SurapolchaiPimlak Charoenkwan Original Article 23 November 2023 Pages: 385 - 393
Correction to: Molecular characteristics of hereditary red blood cell membrane disorders in Thailand: a multi‑center registry Duantida SongdejPacharapan SurapolchaiPimlak Charoenkwan Correction 02 December 2023 Pages: 395 - 395
Clinical characteristics of hepatitis-associated aplastic anemia in children Lingling FuJialu ZhangJie Ma Original Article 12 December 2023 Pages: 397 - 404
Successful treatment with oseltamivir phosphate in children with ITP who failed first-line therapy: a case series report Li-ya LiuBo ZhangYing Ding Original Article 14 December 2023 Pages: 405 - 408
Differential expression of adhesion molecules in sickle cell anemia and gut microbiome effect Mariana DelgadinhoLuísa VeigaMiguel Brito Original Article Open access 28 December 2023 Pages: 409 - 419
Detection and quantification of JAK2V617F copy number by droplet digital PCR versus real-time PCR Sanyun WuYixuan LiLi He Original Article 16 November 2023 Pages: 421 - 426
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib Olga MulasElisabetta AbruzzeseGiovanni Caocci Original Article Open access 28 November 2023 Pages: 427 - 436
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes Tiziano BarbuiAlessandra CarobbioAlessandro Maria Vannucchi Original Article 07 December 2023 Pages: 437 - 442
Correlation between IPSET-t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience Luca TosoniMatteo LiberiMario Tiribelli Original Article 11 December 2023 Pages: 443 - 448
Correction to: Correlation between IPSET‑t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience Luca TosoniMatteo LiberiMario Tiribelli Correction 29 December 2023 Pages: 449 - 449
Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience Marta SobasWanda Knopinska-PoslusznyPau Montesinos Original Article Open access 19 December 2023 Pages: 451 - 461
A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute myeloid leukemia Juanjuan SongWeiya LiHu Zhou Original Article 06 January 2024 Pages: 463 - 473
A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan Yuichi HorigomeMasaki IinoShinsuke Iida Original Article Open access 11 September 2023 Pages: 475 - 488
Liver failure after treatment with inotuzumab and polychemotherapy including PEG-asparaginase in a patient with relapsed Philadelphia chromosome–negative acute lymphoblastic leukemia Daniel FischerRosa ToengesFabian Lang Original Article Open access 24 November 2023 Pages: 489 - 498
Zanubrutinib-lenalidomide-rituximab (ZR2) in unfit diffuse large B-cell lymphoma: efficient and tolerant Yawen WangJiadai XuPeng Liu Original Article 14 November 2023 Pages: 499 - 510
Epigenetically dysregulated NOTCH-Delta-HES signaling cascade can serve as a subtype classifier for acute lymphoblastic leukemia Syeda Saliah HussanMuhammad Shrafat AliSaima Sadaf Original Article 03 November 2023 Pages: 511 - 523
Olverembatinib combined with blinatumomab in treating T315I-mutated Philadelphia chromosome–positive acute lymphoblastic leukemia: two-case report Shengxuan FanLina WangZijian Li Original Article 09 November 2023 Pages: 525 - 532
USF2 promotes autophagy and proliferation in chronic lymphocytic leukemia by inhibiting STUB1-induced NFAT5 ubiquitination Beili ChenYanyi ZhaoQin Zhou Original Article 10 November 2023 Pages: 533 - 544
Distinct FDG PET/CT avidity among newly diagnosed intravascular large B-cell lymphoma patients: a descriptive observational study Danqing ZhaoYan ZhangWei Zhang Original Article 07 November 2023 Pages: 545 - 552
In-depth molecular analysis of lymphomas with lymphoplasmacytic differentiation may provide more precise diagnosis and rational treatment allocation Andrea BrunnerGudrun Carolina Thalhammer-ThurnerElla Willenbacher Original Article Open access 11 November 2023 Pages: 553 - 563
25-Hydroxy vitamin D deficiency is an inferior predictor of peripheral T-cell lymphomas Hao-Rui ShenJing TangWei Xu Original Article 11 November 2023 Pages: 565 - 574
CEAC (oral semustine, etoposide, cytarabine and cyclophosphamide) vs BEAM (carmustine, etoposide, cytarabine, and melphalan) conditioning regimen of autologous stem cell transplantation for diffuse large B-cell lymphoma: a post-hoc, propensity score-matched, cohort study in Chinese patients Tao WangPing LiuJianmin Yang Original Article 06 November 2023 Pages: 575 - 582
Feasibility of allogeneic hematopoietic stem cell transplantation in advanced age Sara Fernandez-LuisDavid Gomez LamasArancha Bermudez Rodriguez Original Article 04 November 2023 Pages: 583 - 591
Non-viral pathogens of infectious diarrhoea post-allogeneic stem cell transplantation are associated with graft-versus-host disease Matthew J. ReesAlexandra RivallandDavid Ritchie Original Article 06 November 2023 Pages: 593 - 602
Myeloablative or reduced-intensity/non-myeloablative hematopoietic cell transplantation for Philadelphia-positive acute lymphoblastic leukemia in adults older than 40 years old — a secondary analysis of a CIBMTR database Irtis de Oliveira Fernandes JuniorLeonardo Javier Arcuri Original Article 09 November 2023 Pages: 603 - 607
Impact of letermovir prophylaxis in CMV reactivation and disease after allogenic hematopoietic cell transplantation: a real-world, observational study Marc BrusosaSonia RuizMaría Queralt Salas Original Article 14 November 2023 Pages: 609 - 621
Absence of blood donors’ anti-SARS-CoV-2 antibodies in pre-storage leukoreduced red blood cell units indicates no role of passive immunity for blood recipients Maddalena CasaleMaria Grazia Di GirolamoSilverio Perrotta Original Article Open access 27 September 2023 Pages: 623 - 629
A comparative study of platelet storage lesion in platelet-rich plasma under cryopreservation E. DangYutong ChenYaozhen Chen Original Article 18 December 2023 Pages: 631 - 643
Analysis of PROC mutations and clinical features in 22 unrelated families with inherited protein C deficiency Fei XuKe ZhangLihong Yang Original Article 10 November 2023 Pages: 645 - 652
Analysis of PROS1 mutations and clinical characteristics in three Chinese families with hereditary protein S deficiency Fei XuXingxing ZhouXiaoli Chen Original Article 04 January 2024 Pages: 653 - 662
Factors associated with inpatient mortality during daunorubicin and cytarabine induction in adults with acute myeloid leukemia—a national inpatient sample analysis Saloni SavaniSuma Sri ChennapragadaShivani Sharma Letter to the Editor 27 October 2023 Pages: 663 - 665
Leukemic non-nodal cyclin D1- and SOX11-negative mantle cell lymphoma with CCND3::IGH rearrangement Lennart TanGoldy BansalKikkeri N Naresh Letter to the Editor 26 October 2023 Pages: 667 - 669
Myeloid sarcoma of the urinary bladder as the presenting feature of secondary acute myeloid leukemia, successfully treated with venetoclax and azacitidine Marko LucijanicCedna Tomasovic-LoncaricRajko Kusec Letter to the Editor 09 November 2023 Pages: 671 - 672
Pulmonary Erdheim-Chester disease successfully treated with vemurafenib Kai-ni ShenLong ChangXin-xin Cao Letter to the Editor 04 November 2023 Pages: 673 - 675
Safe utilization of ruxolitinib in simultaneous primary myelofibrosis and warm autoimmune hemolytic anemia Victor PopeCyrus C. Hsia Letter to the Editor 06 November 2023 Pages: 677 - 679
Cold agglutinin–induced acrocyanosis without hemolytic anemia Wataru KitamuraHiroki KobayashiShoichi Kuyama Letter to the Editor 09 November 2023 Pages: 681 - 683
BRCA2 germline mutation in familial leukaemia with familial breast cancer: a case report Jing WangHeyang ZhangRui Zhang Letter to the Editor Open access 20 November 2023 Pages: 685 - 687
Comment on: Association between anemia and depression: results from NHANES 2005–2018 and Mendelian randomization analyses Tianyu SiXiaolin MaYongming Zhou Letter to the Editor Open access 21 October 2023 Pages: 689 - 691
Comment on: Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosis Na LiHan Cheng Letter to the Editor 14 October 2023 Pages: 693 - 694
